Royal Hobart Hospital — Hobart, Tasmania

Public research footprint of Royal Hobart Hospital, compiled from the ClinicalTrials.gov public registry.

241

Registered studies

Active

Recruiting now

111

Completed

Stopped or withdrawn

Most-studied conditions

Pulmonary Arterial Hypertension · Follicular Lymphoma · Metastatic Non-small Cell Lung Cancer With MTAP Deletion · Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Recently updated registry entries

NCT07023627 — A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin… (Recruiting)
NCT06793215 — A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus… (Recruiting)
NCT07174336 — A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Royal Hobart Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.